SCHEMBL3092307

SCHEMBL3092307

O=C(c1ccc2c(c1)CN(C(=O)c1ccccc1Cl)CC2)N1CCC2(CC1)CCN(c1ccncc1)CC2

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BDKRB1 P46663 1/20 0.56
CYP3A4 P08684 8/20 0.54
CYP2C9 P11712 11/20 0.54
CYP2C19 P33261 8/20 0.54
CYP2D6 P10635 10/20 0.53
CYP1A2 P05177 9/20 0.53
ALDH1A1 P00352 6/20 0.53
TSHR P16473 6/20 0.53
HIF1A Q16665 4/20 0.53
HPGD P15428 2/20 0.52
LMNA P02545 2/20 0.52
HTT P42858 2/20 0.52
SMN1; SMN2 Q16637 6/20 0.51
USP2 O75604 3/20 0.51
MAPK1 P28482 3/20 0.48
HSD17B10 Q99714 2/20 0.46
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
PLA2G1B P04054 1/20 0.44
ATG4B Q9Y4P1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3078114 0.86 BDKRB1 (0.53) BDKRB1CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL3087512 0.86 CYP3A4 (0.54) BDKRB1CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL3088990 0.85 CYP3A4 (0.63) BDKRB1CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL3084016 0.85 BDKRB1 (0.51) BDKRB1CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL3084013 0.85 BDKRB1 (0.51) BDKRB1CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL3089852 0.84 BDKRB1 (0.51) BDKRB1CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL3096314 0.84 CYP3A4 (0.54) BDKRB1CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL3090970 0.84 CYP2C9 (0.57) BDKRB1CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL3082921 0.82 BDKRB1 (0.48) BDKRB1CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL13151431 0.82 CYP3A4 (0.53) BDKRB1CYP3A4CYP2C9CYP2C19CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2393812-B1 SUBSTITUTED SPIROAMIDES AS B1R-MODULATORS GRUENENTHAL GMBH (DE) 2013-07-03 EP claimed
US-8357717-B2 Spiro group-containing amide compounds having bradykinin 1 receptor (B1R) activity GRUENENTHAL GMBH (DE) 2013-01-22 US claimed
US-20100234340-A1 Substituted Spiroamide Compounds GRUENENTHAL GMBH (DE) 2010-09-16 US claimed
EP-2393812-B1 SUBSTITUTED SPIROAMIDES AS B1R-MODULATORS GRUENENTHAL GMBH (DE) 2013-07-03 EP disclosed
US-8357717-B2 Spiro group-containing amide compounds having bradykinin 1 receptor (B1R) activity GRUENENTHAL GMBH (DE) 2013-01-22 US disclosed
US-8357717-B2 Spiro group-containing amide compounds having bradykinin 1 receptor (B1R) activity GRUENENTHAL GMBH (DE) 2013-01-22 US disclosed
US-8357717-B2 Spiro group-containing amide compounds having bradykinin 1 receptor (B1R) activity GRUENENTHAL GMBH (DE) 2013-01-22 US disclosed
US-20100234340-A1 Substituted Spiroamide Compounds GRUENENTHAL GMBH (DE) 2010-09-16 US disclosed
US-20100234340-A1 Substituted Spiroamide Compounds GRUENENTHAL GMBH (DE) 2010-09-16 US disclosed
US-20100234340-A1 Substituted Spiroamide Compounds GRUENENTHAL GMBH (DE) 2010-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234340-A1 Substituted Spiroamide Compounds BDKRB1, BDKRB2, AVPR1B BDKRB1 1/4885CYP3A4 1215/4885CYP2C9 351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.